Safety and Efficacy of Bridging with Low Molecular Weight Heparins: A Systematic Review and Partial Meta-Analysis

Pieter Eijgenraam; Hugo ten Cate; Arina ten Cate-Hoek

doi:10.2174/1381612811319220010

Safety and Efficacy of Bridging with Low Molecular Weight Heparins: A Systematic Review and Partial Meta-Analysis

Pieter Eijgenraam^*, Hugo ten Cate, Arina ten Cate-Hoek

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	4014-4023
Journal	Current Pharmaceutical Design
Volume	19
Issue number	22
DOIs	https://doi.org/10.2174/1381612811319220010
Publication status	Published - Jul 2013

Keywords

Thrombosis
bleeding
systematic review
surgery
anticoagulants
vitamin K antagonists
low molecular weight heparins

Access to Document

10.2174/1381612811319220010

Cite this

@article{e51ff1730e5f415eb5922cfeaed633f5,

title = "Safety and Efficacy of Bridging with Low Molecular Weight Heparins: A Systematic Review and Partial Meta-Analysis",

keywords = "Thrombosis, bleeding, systematic review, surgery, anticoagulants, vitamin K antagonists, low molecular weight heparins",

author = "Pieter Eijgenraam and {ten Cate}, Hugo and {ten Cate-Hoek}, Arina",

year = "2013",

month = jul,

doi = "10.2174/1381612811319220010",

language = "English",

volume = "19",

pages = "4014--4023",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

publisher = "Bentham Science Publishers Ltd.",

number = "22",

}

TY - JOUR

T1 - Safety and Efficacy of Bridging with Low Molecular Weight Heparins: A Systematic Review and Partial Meta-Analysis

AU - Eijgenraam, Pieter

AU - ten Cate, Hugo

AU - ten Cate-Hoek, Arina

PY - 2013/7

Y1 - 2013/7

KW - Thrombosis

KW - bleeding

KW - systematic review

KW - surgery

KW - anticoagulants

KW - vitamin K antagonists

KW - low molecular weight heparins

U2 - 10.2174/1381612811319220010

DO - 10.2174/1381612811319220010

M3 - Article

C2 - 23228321

VL - 19

SP - 4014

EP - 4023

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 22

ER -